64 related articles for article (PubMed ID: 2247844)
1. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.
el-Naggar AK; Ordonez NG; McLemore D; Schultz P; Hickey RC; Samaan N
Surgery; 1990 Dec; 108(6):981-5. PubMed ID: 2247844
[TBL] [Abstract][Full Text] [Related]
2. [Image analysis DNA cytometry in medullary thyroid gland cancer. Comparison with histomorphologic parameters and prognostic effect].
Böttger T; Potratz D; Gabbert H; Schernus B; Stöckle M; Klupp J; Junginger T
Chirurg; 1993 Feb; 64(2):122-9. PubMed ID: 8096455
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
4. [Flow cytometric DNA measurements of thyroid carcinomas].
Tsuchiya A; Sekikawa K; Kimijima I; Suzuki S; Nihei M; Rokkaku Y; Abe R
Gan No Rinsho; 1989 Jul; 35(8):886-90. PubMed ID: 2746864
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma.
Hay ID; Ryan JJ; Grant CS; Bergstralh EJ; van Heerden JA; Goellner JR
Surgery; 1990 Dec; 108(6):972-9; discussion 979-80. PubMed ID: 2247843
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group.
Bergholm U; Adami HO; Bergström R; Bäckdahl M; Akerström G
Acta Chir Scand; 1990 Jan; 156(1):37-46. PubMed ID: 2321439
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study.
Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC
Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612
[TBL] [Abstract][Full Text] [Related]
8. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients.
Scopsi L; Sampietro G; Boracchi P; Del Bo R; Gullo M; Placucci M; Pilotti S
Cancer; 1996 Nov; 78(10):2173-83. PubMed ID: 8918412
[TBL] [Abstract][Full Text] [Related]
9. Influence of cellular DNA content on survival in ovarian carcinoma.
Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in medullary thyroid carcinomas.
Schröder S; Dralle H
Horm Metab Res Suppl; 1989; 21():26-8. PubMed ID: 2807152
[TBL] [Abstract][Full Text] [Related]
11. [The importance of clinical and histologic variables in the prognosis of medullary carcinoma of the thyroid gland].
Separović V; Sarcević B; Kralj Z; Tiska-Rudman L; Knezević F; Vidović K
Lijec Vjesn; 1989; 111(9-10):304-9. PubMed ID: 2633005
[TBL] [Abstract][Full Text] [Related]
12. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
[TBL] [Abstract][Full Text] [Related]
14. DNA content of nasopharyngeal carcinoma: an independent prognostic indicator.
Hsu MM; Chiou CR; Ko JY; Sheen TS; Hong RL; Ting LL
Cancer Detect Prev; 2000; 24(2):119-26. PubMed ID: 10917131
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric DNA analysis of submucosal carcinoma of the esophagus.
Hui AM; Itabashi M; Kato H; Tachimori Y; Watanabe H; Hirota T
Jpn J Clin Oncol; 1994 Feb; 24(1):26-31. PubMed ID: 8126917
[TBL] [Abstract][Full Text] [Related]
16. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.
Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG
Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490
[TBL] [Abstract][Full Text] [Related]
18. Medullary thyroid carcinoma: prognostic factors.
Riddell DA; Lampe HB; Cramer H; Troster M
J Otolaryngol; 1993 Jun; 22(3):180-3. PubMed ID: 7690409
[TBL] [Abstract][Full Text] [Related]
19. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma.
Pyke CM; Hay ID; Goellner JR; Bergstralh EJ; van Heerden JA; Grant CS
Surgery; 1991 Dec; 110(6):964-70; discussion 970-1. PubMed ID: 1745984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
